CARA LAVIER: Open Payments
NPI 1245888908 · CHITTENANGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 14 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $19 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $99 |
| Insulet Corporation | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: TRELEGY ELLIPTA, Omnipod, JARDIANCE, AIRSUPRA, QULIPTA, MOUNJARO, VOQUEZNA, Wegovy.
Industry payments across NY — which companies pay providers there.
